Nimocer 30mg Tablet
Marketer
Micro Labs Ltd
Salt Composition
Nimodipine (30mg)
Overview Nimocer 30mg Tablet
Nimodipine 30mg tablets are prescribed to manage and mitigate further cerebral injury following a subarachnoid hemorrhage (SAH). This calcium channel blocker enhances cerebral perfusion and safeguards against neurological impairment. Treatment with Nimodipine 30mg should commence as quickly as possible post-SAH diagnosis. Dosage and administration frequency are determined by your physician, based on your clinical status and response. The medication can be ingested with or without food, but consistent adherence to your physician's prescribed regimen is crucial for optimal efficacy. Avoid antacids within a two-hour window of administration, as this can compromise absorption. Discontinuation of Nimodipine 30mg requires prior consultation with your doctor; premature cessation may exacerbate your condition. Commonly reported adverse effects include hypotension, tachycardia, cephalalgia, gastrointestinal distress, nausea, dermatological reactions, myalgia, and generalized edema. Report any concerning or persistent side effects to your physician. Prior to commencing Nimodipine 30mg, disclose any pre-existing cardiac or hepatic issues. Interactions may occur with certain anticonvulsants and antihypertensives; a comprehensive medication review with your doctor is essential. Pregnant or lactating individuals should seek medical guidance before initiating this medication. Your blood pressure will be monitored throughout treatment.
Uses of Nimocer 30mg Tablet
Bleeding into the subarachnoid space
Major Benefits of Nimocer 30mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Nimocer 30mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Nimocer 30mg Tablet:
- Decreased blood pressure
- Headache
- Increased heart rate
- Nausea
- Rash
- Stomach discomfort
- Edema (swelling)
- Muscle cramp
How to use Nimocer 30mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 30mg Nimocer tablet whole; avoid chewing, crushing, or breaking it. Consumption may coincide with meals or not, but consistent timing is recommended.
How Nimocer 30mg Tablet works:
Cerebrovascular protection is offered by Nimocer 30mg tablets, a calcium channel antagonist. These tablets ease constriction in cerebral blood vessels, promoting improved blood flow and mitigating brain injury following intracranial hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Nimocer 30mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Nimocer 30mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the potential benefits against the risks prior to any prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Nimocer 30mg tablets are likely incompatible. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Nimocer 30mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Nimocer 30mg Tablets in patients with kidney disease is likely safe. Existing evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverCAUTION
For individuals with severe hepatic impairment, the administration of 30mg Nimocer tablets requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nimocer 30mg Tablet :
NA
Facts to Know About Nimocer 30mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Dihydropyridine carboxylic acid derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Category | Dihydropyridine Calcium Channel Blockers |
3,018 People bought this recently